The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world outcomes of patients with metastatic breast cancer (BC) treated with osteoclast inhibitors (OIs).
 
Yasmin Karimi
No Relationships to Disclose
 
Natasha Purington
No Relationships to Disclose
 
Mina Liu
Patents, Royalties, Other Intellectual Property - (Ex-Husband) various: Acclarent, Luma Therapeutics (I)
 
Allison W. Kurian
Research Funding - Myriad Genetics (Inst)
Other Relationship - Ambry Genetics; Color Genomics; GeneDx/BioReference; Genentech; InVitae
 
George W. Sledge
Leadership - Syndax; Tessa Therapeutics
Stock and Other Ownership Interests - Syndax; Tessa Therapeutics
Consulting or Advisory Role - Radius Health; Symphogen; Synaffix; Syndax; Taiho Pharmaceutical; Verseau Therapeutics
Research Funding - Genentech/Roche (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Radius Health; Tessa Therapeutics; Verseau Therapeutics
 
Douglas W. Blayney
Leadership - Artelo Biosciences
Stock and Other Ownership Interests - Artelo Biosciences; Madorra
Consulting or Advisory Role - Creare; Daiichi Sankyo; Embold Health; Google; Lilly
Research Funding - Amgen (Inst); BeyondSpring Pharmaceuticals (Inst)